Lipoflex Special Infusjonsvæske (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The mixture supplies essential amino acids directly into the bloodstream, serving as building blocks for protein synthesis, supporting nitrogen balance, and stimulating metabolic pathways that maintain muscle mass and organ function when normal dietary intake is insufficient.

The prescribed dose is individualized by the treating physician based on the patient’s weight, metabolic needs, and clinical condition. Dosing calculations consider total protein requirements and renal or hepatic function, and the infusion rate is set by the healthcare team.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing clinician.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lipoflex Special Infusjonsvæske offers a balanced profile of ten essential amino acids in a single formulation, matching the composition of many standard parenteral nutrition solutions. Compared with multi‑component kits, it simplifies preparation but should be evaluated against local formulary standards and patient‑specific amino acid needs.

The solution must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Before use, inspect for particulate matter or discoloration and follow aseptic techniques during preparation.

It is administered intravenously, typically via a central or peripheral venous line, using an infusion pump or controlled drip set. The infusion rate is determined by the prescribing clinician and adjusted according to the patient’s metabolic response and laboratory monitoring.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, significant electrolyte imbalances (e.g., hyperkalemia or metabolic alkalosis), and metabolic complications like severe hyperglycemia. Prompt recognition and management of these events are essential.

Patients with known hypersensitivity to any of the listed amino acids, those with uncontrolled electrolyte disturbances, or individuals for whom parenteral nutrition is contraindicated should not receive the product. Clinical judgment is required for each case.